Sort   by:  
 Page size 
UnknownOngoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAFV600E mutated, microsatellite-stable colon cancer: A case report and literature review.
Not available
S-EPMC10196488 | biostudies-literature
UnknownReal world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment.
Not available
S-EPMC10507096 | biostudies-literature
UnknownEarly mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity.
Not available
S-EPMC12861967 | biostudies-literature
UnknownNonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.
Not available
S-EPMC7572560 | biostudies-literature
Sort   by:  
 Page size